Glycemic Response in Adults with Diabetes
Completed · Not applicable
Conditions studied: Diabetes Mellitus, Type 2
In brief
This will be a randomized crossover design with oral nutrition supplement interventions.
Key facts
- Study ID
- NCT05026424
- Run by
- Société des Produits Nestlé (SPN)
- People needed
- 16
- Starts
- 2021-08-02
- Expected to finish
- 2021-10-05
- Last updated by the study team
- 2024-10-21
Who can join
Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 20-75 years
- Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
- Hemoglobin A1C less than 9.0%
- Fasting blood glucose less than 180 mg/dl
- Hematocrit levels within normal limits
- Having obtained his/her informed consent
You may not qualify if…
- Abnormal thyroid function
- Creatinine >2.0 mg/dl
- Potassium <3.5 mEq/l
- Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
- Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
- Patients with anemia
- Current insulin therapy or insulin therapy within the past month
- Patient who are pregnant
- Allergies to milk, soy or any component of the test product
- Patient who in the investigators assessment cannot be expected to comply with treatment
- Patients with anemia
- Currently participating in another clinical trial
Where it is running
- Orange County Research Center — Tustin, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.